Literature DB >> 33653183

COMMD1 upregulation is involved in copper efflux from ischemic hearts.

Chen Li1, Tao Wang1, Ying Xiao1, Kui Li1, Xia Meng1, Y James Kang1,2.   

Abstract

Copper depletion is associated with myocardial ischemic infarction, in which copper metabolism MURR domain 1 (COMMD1) is increased. The present study was undertaken to test the hypothesis that the elevated COMMD1 is responsible for copper loss from the ischemic myocardium, thus worsening myocardial ischemic injury. Mice (C57BL/6J) were subjected to left anterior descending coronary artery permanent ligation to induce myocardial ischemic infarction. In the ischemic myocardium, copper reduction was associated with a significant increase in the protein level of COMMD1. A tamoxifen-inducible, cardiomyocyte -specific Commd1 knockout mouse (C57BL/6J) model (COMMD1CMC▲/▲) was generated using the Cre-LoxP recombination system. COMMD1CMC▲/▲ and wild-type littermates were subjected to the same permanent ligation of left anterior descending coronary artery. At the 7th day after ischemic insult, COMMD1 deficiency suppressed copper loss in the heart, along with preservation of vascular endothelial growth factor and vascular endothelial growth factor receptor 1 expression and the integrity of the vascular system in the ischemic myocardium. Corresponding to this change, infarct size of ischemic heart was reduced and myocardial contractile function was well preserved in COMMD1CMC▲/▲ mice. These results thus demonstrate that upregulation of COMMD1 is at least partially responsible for copper efflux from the ischemic heart. Cardiomyocyte-specific deletion of COMMD1 helps preserve the availability of copper for angiogenesis, thus suppressing myocardial ischemic dysfunction.

Entities:  

Keywords:  COMMD1; Myocardial ischemia; cardiac function; copper efflux

Mesh:

Substances:

Year:  2020        PMID: 33653183      PMCID: PMC7934151          DOI: 10.1177/1535370220969844

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  49 in total

1.  Identification of a new copper metabolism gene by positional cloning in a purebred dog population.

Authors:  Bart van De Sluis; Jan Rothuizen; Peter L Pearson; Bernard A van Oost; Cisca Wijmenga
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

Review 2.  Copper promotion of myocardial regeneration.

Authors:  Ying Xiao; Tao Wang; Xin Song; Dan Yang; Qing Chu; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-08

3.  Trientine selectively delivers copper to the heart and suppresses pressure overload-induced cardiac hypertrophy in rats.

Authors:  Jiaming Liu; Chen Chen; Yinjie Liu; Xiaorong Sun; Xueqin Ding; Liying Qiu; Pengfei Han; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-24

Review 4.  Copper and homocysteine in cardiovascular diseases.

Authors:  Y James Kang
Journal:  Pharmacol Ther       Date:  2010-12-01       Impact factor: 12.310

Review 5.  Role of copper in regression of cardiac hypertrophy.

Authors:  Lily Zheng; Pengfei Han; Jiaming Liu; Rui Li; Wen Yin; Tao Wang; Wenjing Zhang; Y James Kang
Journal:  Pharmacol Ther       Date:  2014-12-01       Impact factor: 12.310

6.  Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury.

Authors:  M Chevion; Y Jiang; R Har-El; E Berenshtein; G Uretzky; N Kitrossky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice.

Authors:  Laila Elsherif; Lipeng Wang; Jack T Saari; Y James Kang
Journal:  J Nutr       Date:  2004-04       Impact factor: 4.798

8.  Copper and ischemic heart disease.

Authors:  L M Klevay
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

9.  Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice.

Authors:  Youchun Jiang; Corey Reynolds; Chang Xiao; Wenke Feng; Zhanxiang Zhou; Walter Rodriguez; Suresh C Tyagi; John W Eaton; Jack T Saari; Y James Kang
Journal:  J Exp Med       Date:  2007-03-05       Impact factor: 14.307

10.  Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.

Authors:  Xiao Zuo; Daoyin Dong; Miao Sun; Huiqi Xie; Y James Kang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more
  3 in total

1.  The Association of Suppressed Hypoxia-Inducible Factor-1 Transactivation of Angiogenesis With Defective Recovery From Cerebral Ischemic Injury in Aged Rats.

Authors:  Yingjia Guo; Junpeng Zhou; Xianglong Li; Ying Xiao; Jingyao Zhang; Yutao Yang; Li Feng; Y James Kang
Journal:  Front Aging Neurosci       Date:  2021-02-26       Impact factor: 5.750

2.  Dynamic regulation of HIF-1 signaling in the rhesus monkey heart after ischemic injury.

Authors:  Tao Wang; Ying Xiao; Jingyao Zhang; Fujia Jing; Guodan Zeng
Journal:  BMC Cardiovasc Disord       Date:  2022-09-11       Impact factor: 2.174

Review 3.  Regulatory miRNAs in Cardiovascular and Alzheimer's Disease: A Focus on Copper.

Authors:  Anna Sacco; Fabio Martelli; Amit Pal; Claudia Saraceno; Luisa Benussi; Roberta Ghidoni; Mauro Rongioletti; Rosanna Squitti
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.